Uncategorized
The Analyst Verdict: Ionis Pharmaceuticals In The Eyes Of 13 Experts
Latest Ratings for IONS Date Firm Action From To Mar 2022 Guggenheim Initiates Coverage On Buy Mar 2022 Citigroup Initiates Coverage On Sell Feb 2022 SVB Leerink Maintains Market Perform View More Analyst Ratings for IONS View the Latest Analyst Ratings read more
Assessing Tronox Holdings: Insights From 6 Financial Analysts
Latest Ratings for TROX Date Firm Action From To Feb 2022 Deutsche Bank Maintains Buy Feb 2022 Barclays Maintains Overweight Jan 2022 UBS Maintains Buy View More Analyst Ratings for TROX View the Latest Analyst Ratings read more
Where TPG Stands With Analysts
Latest Ratings for TPG Date Firm Action From To Feb 2022 BMO Capital Initiates Coverage On Market Perform Feb 2022 Keefe, Bruyette & Woods Initiates Coverage On Market Perform Feb 2022 Evercore ISI Group Initiates Coverage On In-Line View More Analyst Ratings for TPG View the Latest Analyst Ratings read more
Apple’s Strong Services Growth And iPhone Pricing Power Fuel Analyst’s Confidence Despite Tariff Risks
Rosenblatt analyst maintains Buy rating and $263 price target for Apple despite policy challenges and potential revenue upside in fiscal second-quarter earnings report. Latest Ratings for AAPL Date Firm Action From To Mar 2022 Barclays Maintains Equal-Weight Feb 2022 Tigress Financial Maintains Strong Buy Jan 2022 Credit Suisse Maintains Neutral View More Analyst Ratings for…
